Small Cap
With a marketcap of ₹ 1,879.91 Cr Stock is ranked 1112
Small Cap
With a marketcap of ₹ 1,879.91 Cr Stock is ranked 1112
Beta Drugs Ltd Investment Return
Short Term
Long Term
Beta Drugs Ltd Return Calculator
Beta Drugs Ltd Revenue and Profit and Growth
Strength
- The company's Book Value Per Share (BVPS) is improving consistently for last 2 years
- The company is showing good quarterly growth with YoY Net Profit Growth of 35.2%, the YoY Revenue Growth of 44.17% and the NetProfit for the last quarter of Rs. 13.29 Cr.
- Annual Net Profits is increasing for 3 consecutive years
Weakness
- No Weakness found.
Beta Drugs Ltd Screener FAQs
What types of data can I screen with a Beta Drugs Ltd screener?
The Beta Drugs Ltd screener can be used to check different types of data, such as market capitalization, stock P/E, PB ratio, current price, book value, ROE, 52W high/low, dividend yield, and face value. It also shows short-term and long-term data of the Beta Drugs Ltd.
What is the importance of using a stock screener for analyzing Beta Drugs Ltd?
You can use the Beta Drugs Ltd stock screener to analyze stocks based on specific criteria, helping you choose stocks for investments based on real-time data.
Is the Beta Drugs Ltd Stock Screener suitable for both short-term and long-term investors?
Yes, you can use the Beta Drugs Ltd Stock Screener for both short-term and long-term. Using the short term, you can check data for periods ranging from 1 week to 6 months. On the other hand, if you are looking to invest long-term, you can check data for periods ranging from 1 year to 10 years.
